Symbol="DNLI"
AssetType="Common Stock"
Name="Denali Therapeutics Inc"
Description="Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. The company is headquartered in South San Francisco, California."
CIK="1714899"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="3988945000"
EBITDA="-376710016"
PERatio="None"
PEGRatio="None"
BookValue="7.07"
DividendPerShare="0"
DividendYield="0"
EPS="-2.78"
RevenuePerShareTTM="0.787"
ProfitMargin="0"
OperatingMarginTTM="-3.894"
ReturnOnAssetsTTM="-0.181"
ReturnOnEquityTTM="-0.393"
RevenueTTM="101463000"
GrossProfitTTM="-250269000"
DilutedEPSTTM="-2.78"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.166"
AnalystTargetPrice="58.93"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="35.62"
PriceToBookRatio="4.747"
EVToRevenue="25.36"
EVToEBITDA="-9.23"
Beta="1.31"
num_52WeekHigh="39.43"
num_52WeekLow="21.74"
num_50DayMovingAverage="30.15"
num_200DayMovingAverage="28.52"
SharesOutstanding="136889000"
DividendDate="None"
ExDividendDate="None"
symbol="DNLI"
open="29.10"
high="29.39"
low="28.73"
price="29.14"
volume="326153.00"
latest_trading_day="2023-07-21"
previous_close="28.80"
change="0.34"
change_percent="1.1806%"
aroon_positive_momentum_days="47"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="47"
Volume_recent_avg="738477"
Change_recent_avg="0.01"
Delta_recent_avg="1.12"
Variance_recent_avg="0.56"
Change_ratio_recent_avg="-0.05"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="47"
Aroon_momentum_negative="53"
image_negative_thumbnail_id_1="1097"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0130.jpeg"
image_negative_thumbnail_id_2="488"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0117.jpeg"
image_neutral_thumbnail_id_1="529"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0070.jpeg"
image_neutral_thumbnail_id_2="521"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0078.jpeg"
image_positive_thumbnail_id_1="1009"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0171.jpeg"
image_positive_thumbnail_id_2="605"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0103.jpeg"
image_professor_thumbnail_id_1="1187"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
image_professor_thumbnail_id_2="1175"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
